What is Archer?
Archer Materials operates at the intersection of quantum mechanics and industrial application, specializing in the development of advanced semiconductor technologies. The firm's primary focus centers on the CQ chip, a breakthrough in quantum computing architecture, alongside a sophisticated biochip platform designed for high-precision medical diagnostics. By addressing the limitations of classical computing, Archer provides the infrastructure necessary for next-generation sensing and healthcare analytics. The company serves a critical role in the global technology ecosystem, bridging the gap between theoretical quantum physics and practical, scalable enterprise solutions that address complex, previously unsolvable computational challenges.
How much funding has Archer raised?
Archer has raised a total of $6.9M across 2 funding rounds:
Share Placement
$2M
Stock/Share Issuance
$4.9M
Share Placement (2019): $2M with participation from SPP
Stock/Share Issuance (2026): $4.9M, investors not publicly disclosed
Key Investors in Archer
SPP
A strategic investment entity focused on supporting high-growth technology firms through targeted share placements and capital market participation.
Undisclosed Institutional Investor
An undisclosed investor participating in the funding round, typically focused on long-term value creation in deep-tech and quantum infrastructure.
Undisclosed Strategic Partner
Undisclosed investor participating in the funding round, providing essential capital to support the scaling of advanced semiconductor and biochip technologies.
What's next for Archer?
With the recent influx of capital, Archer is expected to prioritize the commercialization of its quantum hardware roadmap. The strategic allocation of these funds will likely target the expansion of manufacturing capabilities for the CQ chip and the acceleration of clinical validation for its biochip diagnostic tools. As the company moves into this mature phase of development, the focus will shift toward establishing strategic partnerships with global technology integrators and healthcare providers. This growth phase is critical for Archer to maintain its competitive edge in the rapidly evolving quantum sector, ensuring that its research-driven innovations translate into tangible market value and long-term operational sustainability.
See full Archer company page
